Fundz

Aviceda Ophthalmics, Inc. reported raising $8.4 Million in an initial SEC Form D filing, from an offering of $26.2 Million

PRIVATEMar 28, 2022$8.4M of $26.2M raised

Amount Raised

$8.4 Million

$8.4 Million sold, per SEC Form D (first sale Mar 28, 2022)

Round Type

Venture

CambridgeOtherBiotechnology

Quick answer

Aviceda Therapeutics raised $8.4 Million in a funding round, dated March 28, 2022. Aviceda Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Aviceda Therapeutics raise?
Aviceda Therapeutics raised $8.4 Million in a funding round on March 28, 2022.
What does Aviceda Therapeutics do?
Aviceda Therapeutics is a disruptive clinical-stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic..
Where is Aviceda Therapeutics based and how big is it?
Aviceda Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 51 employees.
Who are the decision-makers at Aviceda Therapeutics?
Fundz holds 1 contact at Aviceda Therapeutics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Aviceda Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • DOSE Therapeutics, Inc. raised $10M on May 12, 2022.
  • NanoPhoria raised an undisclosed amount on May 12, 2022.
  • GE HealthCare Technologies raised an undisclosed amount (Corporate Round) on May 12, 2022.
  • Impulse Dynamics raised $101M (Funding Round) on May 12, 2022.
  • BioAegis Therapeutics, Inc. raised $22M on May 11, 2022.
  • Artax Biopharma raised an undisclosed amount (Funding Round) on May 11, 2022.

Who to call at Aviceda Therapeutics, and when

A new round usually means Aviceda Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Aviceda Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Aviceda Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Aviceda Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Aviceda Therapeutics

Location

ONE BROADWAY, 14TH FLOOR

Cambridge, Massachusetts, United States

About

Aviceda Therapeutics is a disruptive clinical-stage biotech company focused on the next generation of immuno-modulators by harnessing the power of glycobiology to address the innate immune system and chronic non-resolving inflammation specifically and profoundly using a propriety HALOS platform Technology. Aviceda is developing glyco-immuno therapeutics targeting devastating ocular and systemic degenerative, fibrotic, and immuno-inflammatory diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Aviceda Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contacts6 people are listed at Aviceda Therapeutics. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Aviceda Therapeutics's next move

See what Strategic adds

Aviceda Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.